S&W Seed Company announced the appointment of appointed Jeffrey Rona as a director of the Company until the 2024 Annual Meeting of Stockholders, and until his successor is duly elected and qualified, or until his earlier death, resignation or removal. Mr. Rona was appointed as a member and chair of the Audit Committee of the Board and as a member of the Compensation Committee of the Board. Mr. Rona has more than 30 years of experience as a Chief Business Officer, Chief Financial Officer, and investment banker.

He is currently the Chief Business and Financial Officer of Ovid Therapeutics, a Nasdaq listed biopharmaceutical company. Prior to joining Ovid Therapeutics, he was the Western Region Managing Director for Danforth Advisors, a life science financial strategy consultancy. Prior to that, Mr. Rona held the titles of Chief Business Officer at GlobeImmune, Chief Financial Officer at AlgoRx Pharmaceuticals, and Director, Investment Banking at UBS.

Over the span of his career, he has completed more than 50 transactions totaling $3.0 billion in deal value. Mr. Rona received his Bachelor of Science degree in accounting from Case Western Reserve University.